Target intelligence / Profile preview

RNA, U4 small nuclear 68, pseudogene (RNU4-68P)

Target
RNU4-68P
Molecular classification
Other (Non-coding RNA pseudogene)
01

Overview

RNU4-68P is a **pseudogene** corresponding to an RNA gene related to the U4 small nuclear RNA family. Pseudogenes are **non-functional sequences** that resemble functional genes but do not produce active RNA or proteins. In this case, RNU4-68P shares sequence similarity to U4 small nuclear RNA, which is an essential component of the spliceosome (the cellular machinery responsible for splicing pre-mRNA). However, due to its status as a pseudogene, RNU4-68P does **not produce functional U4 snRNA** and does not play a known biological, therapeutic, or disease-associated role[4][5]. The canonical, functional version of this family is **RNU4-2** (RNA, U4 small nuclear 2), mutations in which have been associated with neurodevelopmental disorders such as ReNU syndrome, but **RNU4-68P itself has no demonstrated function or clinical significance** as a therapeutic target[1][6]. **Key points:** - RNU4-68P is not a protein nor a functional small nuclear RNA but a pseudogene (a non-functional genetic element)[3][4][5]. - There is no evidence that it is a therapeutic target, plays any role in disease, or interacts with drugs. - The presence of “pseudogene” in its name and gene resources confirms it is not a receptor, enzyme, transporter, or drug target[4][5]. - Information about actual biological functions or disease associations pertains to active genes in the U4 snRNA family (like RNU4-2), not to RNU4-68P. **RNU4-68P should not be considered a valid molecular drug target or a molecule of direct biological or therapeutic interest.**

Other names
RNU4-68P

Beyond the preview

Go deeper on RNA, U4 small nuclear 68, pseudogene (RNU4-68P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 68, pseudogene (RNU4-68P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call